Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?Philipp Gauckler, Andreas Kronbichler, Vincent Audard et al.|Autoimmunity Reviews|2020Cited by 70
Long-Term Outcomes of Rituximab-Treated Adult Patients with PodocytopathiesPhilipp Gauckler, Anna Matyjek, Eleni Kapsia et al.|Journal of the American Society of Nephrology|2024Cited by 29